Maria Godoy
👤 SpeakerAppearances Over Time
Podcast Appearances
They found that tweens who had their own smartphone at age 12 were more likely to have obesity, symptoms of depression, and report insufficient sleep compared to their peers without phones.
And the younger they got their phones, the higher their risk for some of these conditions.
The researchers say they hope their findings will help inform the creation of guidelines on the appropriate age at which kids should first get their own smartphones.
GLP-1 drugs have become increasingly popular among women of reproductive age, but women are advised to stop taking these medications before pregnancy because of potential risks to the fetus.
In the study, researchers from Mass General Brigham reviewed the medical records for nearly 1,800 pregnancies, primarily among women with obesity.
They found that women who stopped GLP-1 medications right before or early in pregnancy also had a higher risk of gaining excess weight, developing gestational diabetes, and hypertensive disorders compared to women who did not take these drugs.
The researchers say more studies are needed on the risks and benefits of taking GLP-1 drugs before having a baby.
GLP-1 drugs have become increasingly popular among women of reproductive age, but women are advised to stop taking these medications before pregnancy because of potential risks to the fetus.
In the study, researchers from Mass General Brigham reviewed the medical records for nearly 1,800 pregnancies, primarily among women with obesity.
They found that women who stopped GLP-1 medications right before or early in pregnancy also had a higher risk of gaining excess weight, developing gestational diabetes, and hypertensive disorders compared to women who did not take these drugs.
The researchers say more studies are needed on the risks and benefits of taking GLP-1 drugs before having a baby.
GLP-1 drugs have become increasingly popular among women of reproductive age, but women are advised to stop taking these medications before pregnancy because of potential risks to the fetus.
In the study, researchers from Mass General Brigham reviewed the medical records for nearly 1,800 pregnancies, primarily among women with obesity.
They found that women who stopped GLP-1 medications right before or early in pregnancy also had a higher risk of gaining excess weight, developing gestational diabetes, and hypertensive disorders compared to women who did not take these drugs.
The researchers say more studies are needed on the risks and benefits of taking GLP-1 drugs before having a baby.